Once-daily vs. twice-daily intrapleural urokinase treatment of complicated parapneumonic effusion in paediatric patients: A randomised, prospective study

International Journal of Clinical Practice

Volumn 60, Issue 10, 2006, Pages 1225-1230

  Wang, J N ^a,b   Yao, C T ^c   Yeh, C N ^c   Liu, C C ^b   Wu, M H ^b   Chuang, H Y ^d   Wu, Jing Ming ^b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^c TAINAN SIN LAU HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Children; Dose frequency; Empyema; Fibrinolytic treatment; Parapneumonic effusion; Urokinase

Indexed keywords

CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; FIBRINOLYTIC AGENT; GENTAMICIN; PARACETAMOL; PENICILLIN G; SULTAMICILLIN; UROKINASE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; FEMALE; FEVER; FOLLOW UP; HOSPITALIZATION; HUMAN; INFANT; IRRITABILITY; LENGTH OF STAY; LUNG ABSCESS; MALE; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; TAIWAN; THORAX DRAINAGE; THORAX PAIN; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFANT; INJECTIONS, INTRALESIONAL; MALE; PLEURAL EFFUSION; PROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 33748579870     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2006.01110.x     Document Type: Article

References (34)

1. Freij BJ, Kusmiesz H, Nelson JD et.al. Parapneumonic effusions and empyema in hospitalized children: A retrospective review of 227 cases. Pediatr Infect Dis 1984; 3: 578-91.
2. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonic effusions in children, 1996 to 2001. Pediatr Infect Dis J 2003; 22: 499-504.
3. Sahn SA. Use of fibrinolytic agents in the management of complicated parapneumonic effusions and empyemas. Thorax 1998; 53 (Suppl. 2): S65-72.
4. Heffner JE. Indications for draining a parapneumonic effusion: An evidence-based approach. Semin Respir Infect 1999; 14: 48-58.
5. Davies RJ, Traill ZC, Gleeson FV. Randomized controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax 1997; 52: 416-21.
6. Bouros D, Schiza S, Patsourakis G et.al. Intrapleural streptokinase versus urokinase in the treatment of complicated parapneumonic effusions: A prospective, double-blind study. Am J Respir Crit Care Med 1997; 155: 291-5.
7. Bouros D, Schiza S, Tzanakis N et.al. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999; 159: 37-42.
8. Tuncozgur B, Ustunsoy H, Sivrikoz MC et.al. Intrapleural urokinase in the management of parapneumonic empyema: A randomised controlled trial. Int J Clin Pract 2001; 55: 658-60.
9. Thomson AH, Hull J, Kumar MR et.al. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002; 57: 343-7.
10. Diacon AH, Theron J, Schuurmans MM et.al. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170: 49-53.
11. Cameron R, Davies HR. Intra-pleural fibrinolytic therapy versus conservative management in the treatment of parapneumonic effusions and empyema. Cochrane Database Syst Rev 2004; (Issue 1): CD002312.
12. Tillett WS, Sherry S. The effect in patients with streptococcal fibrinolysis (streptokinase) and streptococcal desoxyribonuclease on fibrinous purulent, and sanguinous pleural exudations. J Clin Invest 1949; 28: 173-90.
13. Krishnan S, Amin N, Dozor AJ et.al. Urokinase in the management of complicated parapneumonic effusions in children. Chest 1997; 112: 1579-83.
14. Yao CT, Wu JM, Liu CC et.al. Treatment of complicated parapneumonic pleural effusion with intrapleural streptokinase in children. Chest 2004; 125: 566-71.
15. Barbato A, Panizzolo C, Monciotti C et.al. Use of urokinase in childhood pleural empyema. Pediatr Pulmonol 2003; 35: 50-5.
16. Chin NK, Lim TK. Controlled trial of intrapleural streptokinase in the treatment of pleural empyema and complicated parapneumonic effusions. Chest 1997; 111: 275-9.
17. de Benedictis FM, De Giorgi G, Niccoli A et.al. Treatment of complicated pleural effusion with intracavitary urokinase in children. Pediatr Pulmonol 2000; 29: 438-42.
18. Cochran JB, Tecklenburg FW, Turner RB. Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema. Pediatr Crit Care Med 2003; 4: 39-43.
19. Ozcelik C, Inci I, Nizam O et.al. Intrapleural fibrinolytic treatment of multiloculated postpneumonic pediatric empyemas. Ann Thorac Surg 2003; 76: 1849-53.
20. Chapman SJ, Davies RJ. Recent advances in parapneumonic effusion and empyema. Curr Opin Pulm Med 2004; 10: 299-304.
21. Moulton JS, Benkert RE, Weisiger KH et.al. Treatment of complicated pleural fluid collections with image-guided drainage and intracavitary urokinase. Chest 1995; 108: 1252-9.
22. Moulton JS, Moore PT, Mencini RA. Treatment of loculated pleural effusions with transcatheter intracavitary urokinase. Am J Radiol 1989; 153: 941-5.
23. Holden RW. Plasminogen activators: Pharmacology and therapy. Radiology 1990; 174: 993-1001.
24. Light RW. A new classification of parapneumonic effusions and empyema. Chest 1995; 108: 299-301.
25. Robinson LA, Moulton AL, Fleming WH et.al. Intrapleural fibrinolytic treatment of multiloculated thoracic empyemas. Ann Thorac Surg 1994; 57: 803-14.
26. Weinstein M, Restrepo R, Chait PG et.al. Effectiveness and safety of tissue plasminogen activator in the management of complicated parapneumonic effusions. Pediatr 2004; 113: E182-5.
27. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology 2003; 228: 370-8.
28. Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000; 117: 1728-33.
29. Rosen H, Nadkarni V, Theroux M et.al. Intrapleural streptokinase as adjunctive treatment for persistent empyema in pediatric patients. Chest 1993; 103: 1190-3.
30. Spottl F, Kaiser R. Rapid detection and quantitation of precipitating streptokinase-antibodies. Thromb Diath Haemorrh 1974; 32: 608-16.
31. Davies CW, Lok S, Davies RJ. The systemic fibrinolytic activity of intrapleural streptokinase. Am J Respir Crit Care Med 1998; 157: 328-30.
32. Avansino JR, Goldman B, Sawin RS, Flum DR. Primary operative versus nonoperative therapy for pediatric empyema: A meta-analysis. Pediatr 2005; 115: 1652-9.
33. Maskell NA, Davies CW, Nunn AJ et.al. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352: 865-74.
34. Heffner JE. Multicenter trials of treatment for empyema - after all these years. N Engl J Med 2005; 352: 926-8.